| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 114346 | Null | 0.0352383000003056 | 0.25548981 |
| NSC 119915 | 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid | 0.0352383000003056 | 0.48253945 |
| NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0352383000003056 | 0.19178429 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0352383000003056 | 0.24923823 |
| NSC 244404 | Null | 0.0352383000003056 | 0.20525981 |
| NSC 263434 | N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine | 0.0352383000003056 | 0.31408352 |
| NSC 300289 | Pinafide | 0.0352383000003056 | 0.28000853 |
| NSC 303861 | L-Cysteine analog | 0.0352383000003056 | 0.55199239 |
| NSC 32951 | Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone | 0.0352383000003056 | 0.1452018 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0352383000003056 | 0.43508206 |